AGP Picks
View all

Louisiana Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Health Daily.

Press releases published on October 20, 2026

Inseer Appoints Eugene “Woody” Ritchey CEO to Lead Next Phase of Enterprise Growth
Applied Biologics Announces Acceptance for Publication of Interim Results from Randomized Controlled CAMPX Trial Evaluating XWRAP®
Optum and Syneos Health Partner to Advance an Adaptive Clinical Development Model
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
Aeroflow Health Survey Finds Nearly Half of Medicaid Members Are Unprepared for 2027 Work Requirements
Centivo Adds Two Industry Veterans to Leadership Team
Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
Creative Health Care Management Expands Leadership Academy with New Leadership Development Courses for Healthcare Leaders
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026
Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
Vistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs
Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option
Pliant Therapeutics Appoints Craig Blanchette, Ph.D., as Senior Vice President, Research (siRNA)
Acrivon Advances ACR-7280, an Optimized, AP3-Enabled, Potential First-in-Class, Oral CDK11 Inhibitor Toward IND Filing in First Half of 2027
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
Commure Autonomous Coding Achieves Epic Toolbox Designation for Fully Autonomous Coding
The Trigeminal Neuralgia Institute Launches to Drive Research and Bring Specialist Care to Patients
Moleculin Releases Next CEO Corner Segment Highlighting Recent Progress in Annamycin MIRACLE Trial
Palisade Bio Presents Rapid Endoscopic Improvement and New Translational Evidence for PALI-2108 in Inflammatory Bowel Disease at UEG Week 2026
Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Louisiana Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.